Equity Details
Price & Market Data
Price: $0.0₅1
Daily Change: $0.00 / 0.00%
Daily Range: $0.0₅1 - $0.0₅1
Market Cap: $16,545
Daily Volume: 3,000
About Lattice Biologics Ltd. (LBLTF)
Access real-time market insights for Lattice Biologics Ltd. (LBLTF). The stock is trading at 0.0₅1, reflecting a daily change of $0.00 / 0.00%. With a market capitalization of 16,545, it showcases performance metrics including 6-month (N/A) and 1-month (N/A) returns.
Details
Lattice Biologics Ltd., a biotech company, develops, manufactures, and markets biologics products for use in the field of bone regeneration in dental, spine, and general orthopedic indications worldwide. It develops acellular demineralized bone scaffold, a human cortical bone demineralized that are used in various applications in orthopedic, neurological, trauma, oral/maxillofacial, and reconstructive procedures; and acellular dermal matrix that provides a natural collagen tissue scaffold that promotes cellular ingrowth, tissue vascularization, and regeneration The company also develops amniotic fluid-based products, such as AmnioBoost and AmnioBlast. In addition, it sells traditional allografts for multi-disciplinary applications, including orthopedics, neurology, podiatry, and oral/maxillofacial. The company is headquartered in Belgrade, Montana.